Octreotide for advanced hepatocellular carcinoma: a meta-analysis of randomized controlled trials

被引:0
|
作者
Tian-Kang Guo
Xiang-Yong Hao
Bin Ma
Ke-Hu Yang
Yi-Ping Li
Hong-Ling Li
Yuan-Hui Gu
Hui Cai
Ya-Li Liu
Yuan Li
Wei-Peng Zhan
机构
[1] The People’s Hospital of Gansu Province,
[2] Evidence-Based Medicine Center of Lanzhou University,undefined
关键词
Hepatocellular carcinoma; Octreotide; Liver disease; Meta-analysis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1685 / 1692
页数:7
相关论文
共 50 条
  • [21] Radiofrequency ablation versus percutaneous ethanol injection for hepatocellular carcinoma: a meta-analysis of randomized controlled trials
    Biao Yang
    Rui-yu Zan
    Shi-yu Wang
    Xiang-lian Li
    Mao-ling Wei
    Wen-hao Guo
    Xin You
    Jing Li
    Zheng-yin Liao
    World Journal of Surgical Oncology, 13
  • [22] Radiofrequency ablation versus percutaneous ethanol injection for hepatocellular carcinoma: a meta-analysis of randomized controlled trials
    Yang, Biao
    Zan, Rui-yu
    Wang, Shi-yu
    Li, Xiang-lian
    Wei, Mao-ling
    Guo, Wen-hao
    You, Xin
    Li, Jing
    Liao, Zheng-yin
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2015, 13
  • [23] Percutaneous microwave ablation versus radiofrequency ablation of hepatocellular carcinoma: a meta-analysis of randomized controlled trials
    Yu, Qian
    Liu, Chenyu
    Navuluri, Rakesh
    Ahmed, Osman
    ABDOMINAL RADIOLOGY, 2021, 46 (09) : 4467 - 4475
  • [24] Percutaneous microwave ablation versus radiofrequency ablation of hepatocellular carcinoma: a meta-analysis of randomized controlled trials
    Qian Yu
    Chenyu Liu
    Rakesh Navuluri
    Osman Ahmed
    Abdominal Radiology, 2021, 46 : 4467 - 4475
  • [25] Transarterial Chemoembolization Combined with Lenvatinib for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Pei, Xiaxia
    Zhao, Jun
    Wang, Zhiping
    ONCOLOGY, 2024, 102 (08) : 688 - 702
  • [26] Comparison of systemic therapy efficacy in advanced hepatocellular carcinoma: Systematic review and frequentist network meta-analysis of randomized controlled trials.
    Park, Robin
    da Silva, Laercio Lopes
    Nissaisorakarn, Voravech
    Riano, Ivy
    Saeed, Anwaar
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [27] Comparison of Efficacy of Systemic Therapies in Advanced Hepatocellular Carcinoma: Updated Systematic Review and Frequentist Network Meta-Analysis of Randomized Controlled Trials
    Park, Robin
    da Silva, Laercio Lopes
    Nissaisorakarn, Voravech
    Riano, Ivy
    Williamson, Stephen
    Sun, Weijing
    Saeed, Anwaar
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2021, 8 : 145 - 154
  • [28] Molecular targeted therapy and immunotherapy in advanced hepatocellular carcinoma: a systematic review and Bayesian network meta-analysis based on randomized controlled trials
    Zhang, Yun-Long
    Cui, Xin-Jiang
    Xing, Hui
    Ning, Hou-Fa
    Dong, Peng
    Wang, Guang-Zhi
    ANNALS OF MEDICINE, 2023, 55 (02)
  • [29] Octreotide treatment of cancer chemoradiotherapy-induced diarrhoea: a meta-analysis of randomized controlled trials
    Ma, De-Jian
    Li, Zeng-Jun
    Wang, Xi-Yan
    Zhu, Xian-Jun
    Sun, Yan-Lai
    TRANSLATIONAL CANCER RESEARCH, 2019, 8 (06) : 2284 - 2294
  • [30] Radioembolization versus chemoembolization for unresectable hepatocellular carcinoma: a meta-analysis of randomized trials
    Gardini, Andrea Casadei
    Tamburini, Emiliano
    Inarrairaegui, Mercedes
    Frassineti, Giovanni Luca
    Sangro, Bruno
    ONCOTARGETS AND THERAPY, 2018, 11 : 7315 - 7321